Phase 2 PET Clinical Trials
16 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–16 of 16 trials
Recruiting
Phase 2
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
PET/CT ImagingPilot StudyHost Disease Manifestation
M.D. Anderson Cancer Center16 enrolled1 locationNCT07325253
Recruiting
Phase 2
Y-4 to Treat the Postherpetic Neuralgia
Postherpetic NeuralgiaPregabalinY-4
Neurodawn Pharmaceutical Co., Ltd.160 enrolled1 locationNCT07275762
Recruiting
Phase 2
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Prostate CancerRecurrent Prostate CancerPET Positive
National Cancer Institute (NCI)65 enrolled1 locationNCT06096870
Recruiting
Phase 2Phase 3
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
TreatmentSurvivalClassical Hodgkin Lymphoma+6 more
Children's Cancer Group, China96 enrolled1 locationNCT06563245
Not Yet Recruiting
Phase 2Phase 3
A Phase IIb/III Clinical Study to Evaluate the Efficacy and Safety of APC101 in Patients with Postherpetic Neuralgia.
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd333 enrolled1 locationACTRN12625001044415
Recruiting
Phase 2
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
PSMA PET-Positive Castration-Resistant Prostate Cancer
Convergent Therapeutics60 enrolled9 locationsNCT06549465
Recruiting
Phase 2
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
MF,PMF,PPV-MF,PET-MF
Chengdu Zenitar Biomedical Technology Co., Ltd75 enrolled2 locationsNCT06457425
Recruiting
Phase 2
Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Cervical CancerPET/CTRadiotherapy+2 more
Peking Union Medical College Hospital51 enrolled1 locationNCT06353061
Completed
Phase 2
A study that evaluates the effectiveness of oral combined THC/CBD for people with advanced cancer experiencing a range of symptoms.
Psychological effectsCancerFatigue+3 more
Mater Misericordiae Limited144 enrolled6 locationsACTRN12619000037101
Completed
Phase 2
A study that evaluates the effectiveness of oral medicinal cannabis for people with advanced cancer experiencing a range of symptoms.
Psychological effectsCancerFatigue+3 more
Mater Misericordiae Limited144 enrolled6 locationsACTRN12618001220257
Completed
Phase 2
A Phase II, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of topical lidocaine spray in patients with Postherpetic Neuralgia
Postherpetic Neuralgia
Andros Pharmaceuticals Pty Ltd30 enrolled1 locationACTRN12618000852257
Completed
Phase 2
A Randomized, Double-Blind, Crossover, Phase IIa Study Comparing a Single-Application TPM (registered trademark)/Oxycodone Patch versus Vehicle Patch on pain intensity in the Topical Treatment of Patients with Postherpetic Neuralgia
Post-herpetic neuralgia
Phosphagenics Pty Ltd28 enrolled6 locationsACTRN12615000013561
Completed
Phase 2Phase 3
21 day trial into the weight reduction effects of supplementation with 1g and 500mg SolaThin.
weight and appetite in overweight and obese individuals
CYVEX NUTRITION, INC60 enrolled1 locationACTRN12612000198820
Completed
Phase 2
A study of oral EMA401 in the treatment of pain following shingles to see if EMA401 can reduce the level of pain.
Postherpetic Neuralgia
Spinifex Pharmaceuticals Pty Ltd172 enrolled6 locationsACTRN12611000822987
Completed
Phase 2
Fluoxetine for the treatment of repetitive behaviours in children and adolescents with autism: A randomised double-blind placebo-controlled trial.
Repetitve behaviours in autism.
Victorian Medical Insurance Agency146 enrolled3 locationsACTRN12608000173392
Terminated
Phase 2
An investigation of the safety and effect of ACV1 on neuropathic pain in patients with diabetic peripheral neuropathic pain or post-herpetic neuralgia.
Post-herpetic neuralgia (PHN).Post-herpetic neuralgia
Metabolic Pharmaceuticals Ltd.70 enrolled1 locationACTRN12607000201471